header logo image


Page 1,177«..1020..1,1761,1771,1781,179..1,1901,200..»

Sports Medicine | University of Maryland Medical Center

September 8th, 2015 9:44 pm

University of Maryland Orthopaedics provides state-of-the-art sports medicine care to athletes and active individuals of all ages. Our athletic patients span the spectrum of professional, collegiate, and high school competitors. In addition, many of our patients are no longer involved in organized athletics but continue to participate in physical fitness activities. Our Sports Medicine Program emphasizes injury prevention, specialized rehabilitative strategies, and state-of-the-art surgical techniques to treat injuries of the shoulder, elbow, and knee.

We serve as the Official Medical Provider of Maryland Athletics.In addition, Dr. Craig Bennett and our other sports medicine physicians also provide sports medicine services to nearly two dozen area high schools.

Our sports medicine physicians and orthopaedic residents work directly with many of the athletic trainers in Baltimore County, Howard County, and Baltimore City to ensure the same level of care offered to the University of Maryland Terp athletes.

Our comprehensive sports medicine team includes fellowship-trained sports medicine orthopaedic surgeons, primary care sports medicine physicians, athletic trainers, and physical therapists.

In addition to treating sports medicine injuries, our physicians are actively involved in research studies directed at better understanding athletic injuries, improving treatment choices, and getting athletes and active individuals back on their feet faster.

Our physicians' research has been published in many of the most prominent sports medicine journals. Areas of research include ligament and meniscus injuries of the knee, cartilage injuries of the knee, and arthroscopic treatment of shoulder instability in active populations. These research endeavors further the understanding of sporting injuries and help us provide the best possible care to our patients.

We recognize that the needs of our patients differ greatly. While some simply require referral to a physical therapist for outpatient treatment, others require complex surgical reconstruction with length rehabilitation. In the most complex situations it may be necessary to rely on the expertise of other orthopaedic, medical, and physical therapy specialists in caring for our patients. If sub-specialty consultation is required, our team can call upon the vast resources of the University of Maryland Medical System including the R Adams Cowley Shock Trauma Center, University of Maryland Rehabilitation & Orthopaedics Institute formerlyKernan Hospital, and Kernan Physical Therapy Centers.

University of Maryland Orthopaedics;One Texas Station, Suite 300, Timonium, MD 21093

1-877-771-4567 or 410-448-6400

Original post:
Sports Medicine | University of Maryland Medical Center

Read More...

sports medicine | medicine | Britannica.com

September 8th, 2015 9:44 pm

Sports medicine,sports medicine; physical therapy Brand X Pictures/Thinkstockmedical and paramedical supervision, of athletes in training and in competition, with the goal of prevention and treatment of their injuries. Sports medicine entails the application of scientific research and practice to the optimization of health and athletic performance.

Since the revival of the Olympic Games in 1896, increased participation in sport and training for sports have resulted in the need to not only prevent and treat sports injury but also advance the scientific knowledge of the limits of human exercise performance and the causes of fatigue. Moreover, with increased training levels and specialization across the spectrum of recreational sports and with opportunities for sport participants to become professionals, there has been a parallel increase in the careers to support the care and training of athletes and physically active individuals.

sports medicine; physiotherapy Patricia Hofmeester/Shutterstock.comSports medicine is an umbrella term representing a broad array of specialties that bridge the academic disciplines of medicine and physical education as well as the basic sciences (e.g., physiology, chemistry, and physics). Within clinical medicine, physicians in primary care or pediatrics may become team physicians for competitive teams at all levels (interscholastic, intercollegiate, professional, and amateur sports). Other members of a sports medicine team typically include an orthopedic surgeon, a certified athletic trainer, a physical therapist or kinesiotherapist, and a strength-and-conditioning specialist. Other professionals, such as those in the areas of sports nutrition, sports psychology, sports physiology, podiatry, sports vision, sports dentistry, and chiropractic, are valuable consultants.

Although sports medicine is more commonly thought to be related specifically to orthopedic medicine, with respect to the treatment and prevention of injuries occurring in a sport, other medical specialties in cardiology, psychiatry, gynecology, and ophthalmology can also play an important role in comprehensive sports medicine. For example, cardiac rehabilitation is an important area in sports medicine that employs not only doctors but also allied health professionals, such as registered clinical exercise physiologists and nurses. These individuals help patients recover and improve their functional capacity following cardiovascular events such as heart attack or cardiac surgery.

A sports medicine team physician can be called upon to treat a wide variety of sports-related injuries or illnesses. One example is an overuse type of injury, such as a stress fracture in the foot or lower leg. An injury such as this can be caused by any of a variety of problems, including muscle imbalance, muscular weakness arising from a lack of proper strength training, improper footwear or abnormal gait, inadequate mineral or other nutrient intake that upsets the caloric balance necessary for training, hormonal deficiency, and overload of exercise training volume, frequency, and intensity. Thus, to effectively treat an overuse injury, a team physician needs expertise and knowledge in a wide range of sports medicine issues.

sports medicine; exercise ball Supri Suharjoto/Shutterstock.comThe Fdration Internationale de Mdecine du Sport (International Federation of Sports Medicine, or FIMS) is the international organization for national sports medicine associations worldwide. Founded as the Association Internationale Medico-Sportive (AIMS) during the Olympic Winter Games in St. Moritz, Switzerland, in 1928, the organization is today strongly tied to the International Olympic Committee (IOC). The primary goal of FIMS is to support elite athletes in their training and competition by providing outstanding medical care in order to prevent and treat injuries. FIMS also has an interest in facilitating fair play while maximizing performance potential through optimal health habits. The organization fulfills this task by promoting the importance of proper nutrition and rest and by advancing the understanding of ideal training regimens.

In 1954 the American College of Sports Medicine (ACSM) was established to bring together medical doctors, university researchers, and physical educators to advance the study and understanding of the impacts of physical exertion on the human body. The overarching goal of the ACSM is to champion the beneficial aspectsphysical, mental, emotional, and socialof sports and fitness activities that enhance the health and quality of life for all individuals, from youth to the elderly and from frail patients with disease to elite sport performers. The organization has members from around the world whose professional careers span the broad array of disciplines already described; notably, clinicians, researchers, and sport practitioners are within its member ranks.

Other professional sports medicine societies and organizations in the United States include the American Orthopaedic Society for Sports Medicine, the American Medical Society for Sports Medicine, and the American Osteopathic Academy of Sports Medicine. These and many other professional associations are represented as members of the Joint Commission on Sports Medicine and Science.

Many other countries also have sports medicine societies and sports science associations. These entities are often geared specifically toward either clinical medicine or sports science.

The use of exercise and sport as a therapy to prevent chronic disease is well established. The wide range of health benefits of exercise stem from the several key elements that comprise physical fitness: cardiorespiratory endurance, muscular strength, muscular endurance, flexibility, agility, and body composition.

The relationship between regular physical activity and health has been well established worldwide. Governments of numerous countries have published guidelines that describe the amount of physical activity needed for health, although these guidelines may vary slightly.

In 2008 the U.S. government released Physical Activity Guidelines for Americans, the countrys first published set of guidelines on the dose, or amount, of physical activity needed to maintain health for individuals aged six and older. This document was based on a rigorous review by an expert panel of the scientific literature available on exercise and health. The panel found strong evidence indicating that 150 minutes of moderate to vigorous exercise per week for adults helped prevent a wide range of diseases, including cardiovascular disease, stroke, diabetes, hypertension (high blood pressure), certain types of cancer, and depression. This amount of exercise for adults was also associated with a reduced risk of early death, of falls, and of weight gain. There was also moderate evidence indicating that this level of physical activity aids in the prevention of hip fracture, osteoporosis, lung cancer, and endometrial cancer; facilitates weight maintenance after weight loss; and improves sleep quality.

The 2008 U.S. report also indicated that for individuals aged 6 to 17 the baseline dose of exercise needed to obtain health benefits was 60 minutes or more of physical activity every day (physical activity was defined as aerobic or endurance exercise of moderate or vigorous intensity). The greatest health benefits were associated with vigorous activity at least three days per week. Muscle-strengthening and bone-strengthening activities performed at least three days per week for children and at least two days per week for adults were also found to improve health.

In Canada, youths are encouraged to obtain even more minutes of daily activity (60 moderate and 30 vigorous minutes). In general, similar guidelines have been established for all individuals, and they are not considered to be optimal training doses for various sports and athletes. Training for competitive sports generally requires additional sports medicine expertise.

Exercise in therapeutic doses is powerful in preventive medicine. Therefore, in the broadest of terms, sports medicine is applicable to any individual who includes movement as a part of his or her daily life as well as to those who compete on teams or in individual sportsfrom youth to masters-level events.

Continued here:
sports medicine | medicine | Britannica.com

Read More...

Sports Medicine Doctors in Palo Alto – Palo Alto Medical …

September 8th, 2015 4:44 am

Main content

The Sports Medicine Department of the Palo Alto Medical Foundation specializes in comprehensive care of injuries for active people. Our sports medicine specialists are highly skilled, with fellowships in the fields of sports medicine.

Our program is a pioneer in the field of sports medicine, and our doctors have substantial experience treating a wide range of sports conditions, from ACL and meniscus tears to rotator cuff injury and tennis elbow. Our doctors serve as consultants to many professional sports teams, and work with our skilled medical staff to provide comprehensive care to athletes.

Every active person is welcome in our practice. Our goal is to provide the highest quality care to all our patients to help them recover quickly from their injuries and return to their active lifestyles. In doing so, we strive to provide you with the best sports medicine doctors in Northern California.

Visit any of our highly qualified sports medicine doctors to get the quality treatment you need to return to your active lifestyle.

Frank Chen, M.D.

Colin L. Eakin, M.D.

Sally S. Harris, M.D., MPH

Warren King, M.D.

Back to top

Read more:
Sports Medicine Doctors in Palo Alto - Palo Alto Medical ...

Read More...

Genome Medicine

September 7th, 2015 6:46 pm

Medicine in the post-genomic era

Genome Medicine publishes peer-reviewed research articles, new methods, software tools, reviews and comment articles in all areas of medicine studied from a post-genomic perspective. Areas covered include, but are not limited to, disease genomics (including genome-wide association studies and sequencing-based studies), disease epigenomics, pathogen and microbiome genomics, immunogenomics, translational genomics, pharmacogenomics and personalized medicine, proteomics and metabolomics in medicine, systems medicine, and ethical, legal and social issues.

There has been an error retrieving the data. Please try again.

DNA-PK inhibition boosts Cas9-mediated HDR

Transient pharmacological inhibition of DNA-PKcs can stimulate homology-directed repair following Cas9-mediated induction of a double strand break, and is expected to reduce the downstream workload.

Genomics of epilepsy

Candace Myers and Heather Mefford review how advances in genomic technologies have aided variant discovery, leading to a rapid increase in our understanding of epilepsy genetics.

CpG sites associated with atopy

Thirteen novel epigenetic loci associated with atopy and high IgE were found that could serve 55 as candidate loci; of these, four were within genes with known roles in the immune response.

Longitudinal 'omic profiles

A pilot study quantifying gene expression and methylation profile consistency over a year shows high longitudinal consistency, with individually extreme transcript abundance in a small number of genes which may be useful for explaining medical conditions or guiding personalized health decisions.

Ovarian cancer landscape

Exome sequencing of mucinous ovarian carcinoma tumors reveals multiple mutational targets, suggesting tumors arise through many routes, and shows this group of tumors is distinct from other subtypes.

NGS-guided cancer therapy

Jeffrey Gagan and Eliezer Van Allen review how next-generation sequencing can be incorporated into standard oncology clinical practice and provide guidance on the potential and limitations of sequencing.

ClinLabGeneticist

A platform for managing clinical exome sequencing data that includes data entry, distribution of work assignments, variant evaluation and review, selection of variants for validation, report generation.

Semantic workflow for clinical omics

A clinical omics analysis pipeline using the Workflow Instance Generation and Specialization (WINGS) semantic workflow platform demonstrates transparency, reproducibility and analytical validity.

Stephen McMahon and colleagues review treatments for pain relief, which are often inadequate, and discuss how understanding of the genomic and epigenomic mechanisms might lead to improved drugs.

View more review articles

Exploiting single-molecule transcript sequencing for eukaryotic gene prediction

Minoche AE, Dohm JC, Schneider J, Holtgrwe D, Viehver P, Montfort M, Rosleff Srensen T, Weisshaar B et al.

Genome Biology 2015, 16:184

Analysis methods for studying the 3D architecture of the genome

Ay F and Noble WS

Genome Biology 2015, 16:183

Graded gene expression changes determine phenotype severity in mouse models of CRX-associated retinopathies

Ruzycki PA, Tran NM, Kefalov VJ, Kolesnikov AV and Chen S

Genome Biology 2015, 16:171

Predicting the spatial organization of chromosomes using epigenetic data

Mourad R and Cuvier O

Genome Biology 2015, 16:182

See the original post here:
Genome Medicine

Read More...

Genetic Engineering – HowStuffWorks

September 7th, 2015 6:46 pm

Genetic Engineering, the process of extracting DNA (deoxyribonucleic acid, which makes up the genes of all living things) from one organism and combining it with the DNA of another organism, thus introducing new hereditary traits into the recipient organism. The nature and characteristics of every living creature is determined by the special combinations of genes carried by its cells. The slightest alteration in these combinations can bring about significant changes in an organism and also its progeny. The science of devising techniques of modifying or controlling genes and genetic combinations is referred to as genetic engineering. It was practiced in one form or another in the past by farmers and agriculturists trying to create economically viable species of plants and animals through various breeding techniques Genetic engineering, as a science, was developed in the mid-1970's primarily to create new strains of microorganisms that produce certain chemicals useful in manufacturing or as drugs. Genetic engineering is now also applied to improving plants and creating transgenic animals (animals containing foreign genetic material).

Some persons oppose genetic engineering on religious, ethical, or social grounds. Among the religious questions is whether humans have the right to transfer traits from one organism to another. A social concern is the possibility of creating harmful organisms that, if accidentally released into the environment, could cause epidemics.The creation of human clones, for example, is facing serious opposition especially on moral grounds. Organizations, such as the National Institutes of Health (NIH), are seeking to control the harmful effects of genetic engineering by imposing guidelines and safety measures for genetic experimentation. Treatment of hereditary defects through gene transplantation and controlled interchange of genes between specified species was approved in 1985 and 1987 respectively by the NIH and the National Academy of Sciences. The USDA has framed regulations for the genetic alteration of plants by plant breeders.

The U.S. Supreme Court ruled in 1980 that genetically engineered microorganisms could be patented. In 1988 the U.S. Patent and Trademark Office issued its first patent for a higher form of life, a transgenic mouse that is highly susceptible to certain cancers that appear frequently in humans. This mouse is used in cancer research.

Link:
Genetic Engineering - HowStuffWorks

Read More...

Stem Cells from Fat Plastic Surgerys New Frontier …

September 7th, 2015 6:46 pm

There is no doubt that the most exciting frontier in medicine now is the use of stem cells. Stem cells have the power to restore beauty, heal damaged tissues, and the potential to treat and cure some diseases.

Up until recently the media has largely focused on the more controversial embryonic stem cells. These are stem cells derived from embryos. The potential uses of these cells to cure and treat diseases remain vast, but the controversial source of the cells poses ethical questions which have delayed medical progress.

During the past decade, researchers have discovered that stem cells can also be extracted from your own fat tissue. These adult stem cells have the same potential as embryonic stem cells, except for the ability to differentiate into sperm or ova. Unlike embryonal stem cells, stem cells extracted from your own fat are abundant, easily available, and pose no ethical or political controversy.

Due to FDA regulations, stem cell therapies to treat diseases are not yet available in the U.S. unless you are part of a clinical trial. In this capacity they are considered to be drug therapy and subject to very strict regulation. Therefore, patients not enrolled in these trials are currently traveling outside of the United States to get these therapies.

But using your own (autologous) stem cells to restore a more youthful appearance is available now, from experienced plastic surgeons here is the U.S. There is no need to travel to China, Korea, or Europe to get stem cell enhanced facial rejuvenation or breast augmentation. These therapies do not fall under the FDAs drug therapy classification and are therefore not regulated as such because: 1) the injections are performed in the same operative session as the liposuction procedure to remove the fat; 2) the stem cells have been only minimally manipulated; and 3) the stem cell enhanced fat transfer does not alter the original relevant biologic function of the stem cell. Thus, when the cosmetic enhancement is performed in the same operative session, it is not regulated by drug therapy guidelines.

However, if your autologous stem cells are reinjected in a separate or second operative session, it is unclear whether the FDA considers that application to be a drug therapy, even though it is used for the same cosmetic purpose. There is currently an intense legal debate about what constitutes drug therapy.

Plastic Surgeons have been extracting and reinjecting fat cells into tissues for over a decade. Experienced fat grafting surgeons have known that successful fat grafting is highly dependent on the techniques used for extracting, processing, and reinjection of the fat cells. Surgeons are beginning to understand that fat processing techniques which result in high concentrations of adult stem cells produce not only long lasting results, but also have therapeutic results in injured tissues.

To perform stem cell enhanced fat grafting, fat is first extracted by liposuction using low negative pressure. The fat is then processed. Proper fat processing techniques include centrifugation and decanting of the extracted fat. Long lasting results are only achieved with proper fat processing techniques.

In contrast, surgeons who rinse the tissue decrease stem cell adherence to fat cells, and do not increase the concentration of stem cells. These less concentrated grafts have a smaller percentage of success.

Reinjection of the fat must be performed in very small quantities and distributed through all tissue layers to facilitate reestablishment of blood flow to the fat grafts.

Examples of stem cell enhanced fat transfers which can be performed in the same operative session by plastic surgeons at the present time include:

Other areas of stem cell therapy which are being investigated and currently developed are:

Stem cell therapy is a paradigm shift in cosmetic surgery. Instead of the surgeon using his talents to create the illusion of a more youthful body, the surgeon guides your body to rejuvenate itself!!

By Dr. Ricardo L Rodriguez Board Certified Plastic Surgeon Baltimore, Maryland Ricardo L Rodriguez on Google +

Posted in Fat Stem Cells

Continued here:
Stem Cells from Fat Plastic Surgerys New Frontier ...

Read More...

My new neighbor in Sacramento: a fat stem cell clinic …

September 7th, 2015 6:46 pm

For years Ive been writing about stem cell clinics that sell non-FDA approved stem cell treatments to vulnerable patients right here in America.

These clinics have been sprouting up like mushrooms across the US and their numbers may be above200 today overall. As a result perhaps it was inevitable that one would arrive in a locale near me.

Tomorrow, July 11, reportedly the Irvine Stem Cell Treatment Center will open a Sacramento, CA branch.The doctor there will apparently be Thomas A. Gionis (picture from press release). This private, for-profit clinic has no affiliation with UC Davis School of Medicine in Sacramento where Im located.

The stem cell clinic Sacramento branch will sell transplants of fat stem cells in the form of something called stromal vascular fraction or SVF, which I believe is almost certainly a drug. To my knowledge this clinic and the large chain that it belongs to called Cell Surgical Network (CSN), do not have FDA approval to use SVF.

Both publicly and to me on this blog, CSN continues to arguethat it doesnt need FDA approval (here,hereandhere), but recent FDA draft guidances sure suggest otherwise in my view. Of course if the FDA never takes action on the use of SVF then how are we all supposed to interpret that? WithoutFDA action or finalized guidelines, is it formally possible that the FDA could back down on SVF?

This clinic will reportedly sell SVF to treat a dizzying array of conditions having nothing to do with fat:

Emphysema, COPD, Asthma, Heart Failure, Heart Attack, Parkinsons Disease, Stroke, Traumatic Brain Injury, Lou Gehrigs Disease, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohns Disease, Muscular Dystrophy, Inflammatory Myopathies, and Degenerative Orthopedic Joint Conditions (Knee, Shoulder, Hip, Spine).

To me as a scientist the use of SVF to treat all these very different conditions does not make good common sense.

It would also seem arguably to be quite likely be considered non-homologous use by the FDA, a standing that would also automatically make this a drug requiring FDA pre-approval. Non-homologous use means using a biological product of a certain kind that is not homologous (not the same or similar in origin) to the tissue being treated. For example, fat is not the same as the brain or other central nervous system tissue that is involved in several of the conditions on the clinic menu. Same goes for cardiac muscle, airways, etc.

The use of a non-FDA approved product in a largely non-homologous manner increases risks for patients. Note that these stem cell transplants are also very expensive with little evidence in the way of published data of benefit.

The CSN stem cell clinic in Sacramento will be located at the New Body MD Surgical Center, just about 10 minutes from my office. I plan on paying them a visit at some point. Lets see how that goes. Will they let me in?

. Bookmark the

.

Go here to see the original:
My new neighbor in Sacramento: a fat stem cell clinic ...

Read More...

Cell culture – Wikipedia, the free encyclopedia

September 7th, 2015 4:47 am

Cell culture is the process by which cells are grown under controlled conditions, generally outside of their natural environment. In practice, the term "cell culture" now refers to the culturing of cells derived from multicellular eukaryotes, especially animal cells, in contrast with other types of culture that also grow cells, such as plant tissue culture, fungal culture, and microbiological culture (of microbes). The historical development and methods of cell culture are closely interrelated to those of tissue culture and organ culture. Viral culture is also related, with cells as hosts for the viruses.

The laboratory technique of maintaining live cell lines (a population of cells descended from a single cell and containing the same genetic makeup) separated from their original tissue source became more robust in the middle 20th century.[1][2]

The 19th-century English physiologist Sydney Ringer developed salt solutions containing the chlorides of sodium, potassium, calcium and magnesium suitable for maintaining the beating of an isolated animal heart outside of the body.[3] In 1885, Wilhelm Roux removed a portion of the medullary plate of an embryonic chicken and maintained it in a warm saline solution for several days, establishing the principle of tissue culture.[4]Ross Granville Harrison, working at Johns Hopkins Medical School and then at Yale University, published results of his experiments from 1907 to 1910, establishing the methodology of tissue culture.[5]

Cell culture techniques were advanced significantly in the 1940s and 1950s to support research in virology. Growing viruses in cell cultures allowed preparation of purified viruses for the manufacture of vaccines. The injectable polio vaccine developed by Jonas Salk was one of the first products mass-produced using cell culture techniques. This vaccine was made possible by the cell culture research of John Franklin Enders, Thomas Huckle Weller, and Frederick Chapman Robbins, who were awarded a Nobel Prize for their discovery of a method of growing the virus in monkey kidney cell cultures.

Cells can be isolated from tissues for ex vivo culture in several ways. Cells can be easily purified from blood; however, only the white cells are capable of growth in culture. Mononuclear cells can be released from soft tissues by enzymatic digestion with enzymes such as collagenase, trypsin, or pronase, which break down the extracellular matrix. Alternatively, pieces of tissue can be placed in growth media, and the cells that grow out are available for culture. This method is known as explant culture.

Cells that are cultured directly from a subject are known as primary cells. With the exception of some derived from tumors, most primary cell cultures have limited lifespan.

An established or immortalized cell line has acquired the ability to proliferate indefinitely either through random mutation or deliberate modification, such as artificial expression of the telomerase gene. Numerous cell lines are well established as representative of particular cell types.

For the majority of isolated primary cells, they undergo the process of senescence and stop dividing after a certain number of population doublings while generally retaining their viability (described as the Hayflick limit).

Cells are grown and maintained at an appropriate temperature and gas mixture (typically, 37C, 5% CO2 for mammalian cells) in a cell incubator. Culture conditions vary widely for each cell type, and variation of conditions for a particular cell type can result in different phenotypes.

Aside from temperature and gas mixture, the most commonly varied factor in culture systems is the cell growth medium. Recipes for growth media can vary in pH, glucose concentration, growth factors, and the presence of other nutrients. The growth factors used to supplement media are often derived from the serum of animal blood, such as fetal bovine serum (FBS), bovine calf serum, equine serum, and porcine serum. One complication of these blood-derived ingredients is the potential for contamination of the culture with viruses or prions, particularly in medical biotechnology applications. Current practice is to minimize or eliminate the use of these ingredients wherever possible and use human platelet lysate (hPL). This eliminates the worry of cross-species contamination when using FBS with human cells. hPL has emerged as a safe and reliable alternative as a direct replacement for FBS or other animal serum. In addition, chemically defined media can be used to eliminate any serum trace (human or animal), but this cannot always be accomplished with different cell types. Alternative strategies involve sourcing the animal blood from countries with minimum BSE/TSE risk, such as The United States, Australia and New Zealand,[6] and using purified nutrient concentrates derived from serum in place of whole animal serum for cell culture.[7]

Plating density (number of cells per volume of culture medium) plays a critical role for some cell types. For example, a lower plating density makes granulosa cells exhibit estrogen production, while a higher plating density makes them appear as progesterone-producing theca lutein cells.[8]

Cells can be grown either in suspension or adherent cultures. Some cells naturally live in suspension, without being attached to a surface, such as cells that exist in the bloodstream. There are also cell lines that have been modified to be able to survive in suspension cultures so they can be grown to a higher density than adherent conditions would allow. Adherent cells require a surface, such as tissue culture plastic or microcarrier, which may be coated with extracellular matrix (such as collagen and laminin) components to increase adhesion properties and provide other signals needed for growth and differentiation. Most cells derived from solid tissues are adherent. Another type of adherent culture is organotypic culture, which involves growing cells in a three-dimensional (3-D) environment as opposed to two-dimensional culture dishes. This 3D culture system is biochemically and physiologically more similar to in vivo tissue, but is technically challenging to maintain because of many factors (e.g. diffusion).

Cell line cross-contamination can be a problem for scientists working with cultured cells.[9] Studies suggest anywhere from 1520% of the time, cells used in experiments have been misidentified or contaminated with another cell line.[10][11][12] Problems with cell line cross-contamination have even been detected in lines from the NCI-60 panel, which are used routinely for drug-screening studies.[13][14] Major cell line repositories, including the American Type Culture Collection (ATCC), the European Collection of Cell Cultures (ECACC) and the German Collection of Microorganisms and Cell Cultures (DSMZ), have received cell line submissions from researchers that were misidentified by them.[13][15] Such contamination poses a problem for the quality of research produced using cell culture lines, and the major repositories are now authenticating all cell line submissions.[16] ATCC uses short tandem repeat (STR) DNA fingerprinting to authenticate its cell lines.[17]

To address this problem of cell line cross-contamination, researchers are encouraged to authenticate their cell lines at an early passage to establish the identity of the cell line. Authentication should be repeated before freezing cell line stocks, every two months during active culturing and before any publication of research data generated using the cell lines. Many methods are used to identify cell lines, including isoenzyme analysis, human lymphocyte antigen (HLA) typing, chromosomal analysis, karyotyping, morphology and STR analysis.[17]

One significant cell-line cross contaminant is the immortal HeLa cell line.

As cells generally continue to divide in culture, they generally grow to fill the available area or volume. This can generate several issues:

Among the common manipulations carried out on culture cells are media changes, passaging cells, and transfecting cells. These are generally performed using tissue culture methods that rely on aseptic technique. Aseptic technique aims to avoid contamination with bacteria, yeast, or other cell lines. Manipulations are typically carried out in a biosafety hood or laminar flow cabinet to exclude contaminating micro-organisms. Antibiotics (e.g. penicillin and streptomycin) and antifungals (e.g.amphotericin B) can also be added to the growth media.

As cells undergo metabolic processes, acid is produced and the pH decreases. Often, a pH indicator is added to the medium to measure nutrient depletion.

In the case of adherent cultures, the media can be removed directly by aspiration, and then is replaced. Media changes in non-adherent cultures involve centrifuging the culture and resuspending the cells in fresh media.

Passaging (also known as subculture or splitting cells) involves transferring a small number of cells into a new vessel. Cells can be cultured for a longer time if they are split regularly, as it avoids the senescence associated with prolonged high cell density. Suspension cultures are easily passaged with a small amount of culture containing a few cells diluted in a larger volume of fresh media. For adherent cultures, cells first need to be detached; this is commonly done with a mixture of trypsin-EDTA; however, other enzyme mixes are now available for this purpose. A small number of detached cells can then be used to seed a new culture. Some cell cultures, such as RAW cells are mechanically scraped from the surface of their vessel with rubber scrapers.

Another common method for manipulating cells involves the introduction of foreign DNA by transfection. This is often performed to cause cells to express a protein of interest. More recently, the transfection of RNAi constructs have been realized as a convenient mechanism for suppressing the expression of a particular gene/protein. DNA can also be inserted into cells using viruses, in methods referred to as transduction, infection or transformation. Viruses, as parasitic agents, are well suited to introducing DNA into cells, as this is a part of their normal course of reproduction.

Cell lines that originate with humans have been somewhat controversial in bioethics, as they may outlive their parent organism and later be used in the discovery of lucrative medical treatments. In the pioneering decision in this area, the Supreme Court of California held in Moore v. Regents of the University of California that human patients have no property rights in cell lines derived from organs removed with their consent.[19]

It is possible to fuse normal cells with an immortalised cell line. This method is used to produce monoclonal antibodies. In brief, lymphocytes isolated from the spleen (or possibly blood) of an immunised animal are combined with an immortal myeloma cell line (B cell lineage) to produce a hybridoma which has the antibody specificity of the primary lymphocyte and the immortality of the myeloma. Selective growth medium (HA or HAT) is used to select against unfused myeloma cells; primary lymphoctyes die quickly in culture and only the fused cells survive. These are screened for production of the required antibody, generally in pools to start with and then after single cloning.

A cell strain is derived either from a primary culture or a cell line by the selection or cloning of cells having specific properties or characteristics which must be defined. Cell strains are cells that have been adapted to culture but, unlike cell lines, have a finite division potential. Non-immortalized cells stop dividing after 40 to 60 population doublings[20] and, after this, they lose their ability to proliferate (a genetically determined event known as senescence).[21]

Mass culture of animal cell lines is fundamental to the manufacture of viral vaccines and other products of biotechnology.

Biological products produced by recombinant DNA (rDNA) technology in animal cell cultures include enzymes, synthetic hormones, immunobiologicals (monoclonal antibodies, interleukins, lymphokines), and anticancer agents. Although many simpler proteins can be produced using rDNA in bacterial cultures, more complex proteins that are glycosylated (carbohydrate-modified) currently must be made in animal cells. An important example of such a complex protein is the hormone erythropoietin. The cost of growing mammalian cell cultures is high, so research is underway to produce such complex proteins in insect cells or in higher plants, use of single embryonic cell and somatic embryos as a source for direct gene transfer via particle bombardment, transit gene expression and confocal microscopy observation is one of its applications. It also offers to confirm single cell origin of somatic embryos and the asymmetry of the first cell division, which starts the process.

Research in tissue engineering, stem cells and molecular biology primarily involves cultures of cells on flat plastic dishes. This technique is known as two-dimensional (2D) cell culture, and was first developed by Wilhelm Roux who, in 1885, removed a portion of the medullary plate of an embryonic chicken and maintained it in warm saline for several days on a flat glass plate. From the advance of polymer technology arose today's standard plastic dish for 2D cell culture, commonly known as the Petri dish. Julius Richard Petri, a German bacteriologist, is generally credited with this invention while working as an assistant to Robert Koch. Various researchers today also utilize culturing laboratory flasks, conicals, and even disposable bags like those used in single-use bioreactors.

Aside from Petri dishes, scientists have long been growing cells within biologically derived matrices such as collagen or fibrin, and more recently, on synthetic hydrogels such as polyacrylamide or PEG. They do this in order to elicit phenotypes that are not expressed on conventionally rigid substrates. There is growing interest in controlling matrix stiffness,[22] a concept that has led to discoveries in fields such as:

Cell culture in three dimensions has been touted as "Biology's New Dimension".[37] Nevertheless, the practice of cell culture remains based on varying combinations of single or multiple cell structures in 2D.[38] That being said, there is an increase in use of 3D cell cultures in research areas including drug discovery, cancer biology, regenerative medicine and basic life science research.[39] There are a variety of platforms used to facilitate the growth of three-dimensional cellular structures such as nanoparticle facilitated magnetic levitation,[40] gel matrices scaffolds, and hanging drop plates.[41]

3D Cell Culturing by Magnetic Levitation method (MLM) is the application of growing 3D tissue by inducing cells treated with magnetic nanoparticle assemblies in spatially varying magnetic fields using neodymium magnetic drivers and promoting cell to cell interactions by levitating the cells up to the air/liquid interface of a standard petri dish. The magnetic nanoparticle assemblies consist of magnetic iron oxide nanoparticles, gold nanoparticles, and the polymer polylysine. 3D cell culturing is scalable, with the capability for culturing 500 cells to millions of cells or from single dish to high-throughput low volume systems.

Cell culture is a fundamental component of tissue culture and tissue engineering, as it establishes the basics of growing and maintaining cells in vitro. The major application of human cell culture is in stem cell industry, where mesenchymal stem cells can be cultured and cryopreserved for future use. Tissue engineering potentially offers dramatic improvements in low cost medical care for hundreds of thousands of patients annually.

Vaccines for polio, measles, mumps, rubella, and chickenpox are currently made in cell cultures. Due to the H5N1 pandemic threat, research into using cell culture for influenza vaccines is being funded by the United States government. Novel ideas in the field include recombinant DNA-based vaccines, such as one made using human adenovirus (a common cold virus) as a vector,[42][43] and novel adjuvants.[44]

Plant cell cultures are typically grown as cell suspension cultures in a liquid medium or as callus cultures on a solid medium. The culturing of undifferentiated plant cells and calli requires the proper balance of the plant growth hormones auxin and cytokinin.

Cells derived from Drosophila melanogaster (most prominently, Schneider 2 cells) can be used for experiments which may be hard to do on live flies or larvae, such as biochemical studies or studies using siRNA. Cell lines derived from the army worm Spodoptera frugiperda, including Sf9 and Sf21, and from the cabbage looper Trichoplusia ni, High Five cells, are commonly used for expression of recombinant proteins using baculovirus.

For bacteria and yeasts, small quantities of cells are usually grown on a solid support that contains nutrients embedded in it, usually a gel such as agar, while large-scale cultures are grown with the cells suspended in a nutrient broth.

The culture of viruses requires the culture of cells of mammalian, plant, fungal or bacterial origin as hosts for the growth and replication of the virus. Whole wild type viruses, recombinant viruses or viral products may be generated in cell types other than their natural hosts under the right conditions. Depending on the species of the virus, infection and viral replication may result in host cell lysis and formation of a viral plaque.

See the rest here:
Cell culture - Wikipedia, the free encyclopedia

Read More...

Endocrinology | Endocrinology Services St Louis Missouri …

September 6th, 2015 7:44 am

The Endocrinology, Diabetes and Metabolism group at Barnes-Jewish Hospital is consistently ranked among the top clinical programs in endocrinology, diabetes and metabolism in the United States. Washington University physicians in the group provide consultations, co-management or, in some cases, ongoing care for adults patients with endocrine and metabolic disorders.

Endocrinology, Metabolism and Lipid consultants, under the direction of Clay F. Semenkovich, MD, provide patients with state-of-the-art clinical diagnostic and therapeutic approaches, based on the most current research findings.

Our group provides a resource to referring physicians and patients for diagnosis and treatment of disorders ranging from the ordinary to the most challenging. We provide consultations, co-management or, in some cases, ongoing care for adult patients with endocrine-metabolic diseases.

Endocrine diseases include those of the: thyroid, pituitary, parathyroid, adrenal, gonadal (sex gland) and pancreatic islet disorders. Metabolic diseases include: diabetes, dyslipidemia (high cholesterol) and osteoporosis (brittle bones). Lipid metabolic disorders include patients with high triglycerides, high cholesterol, and low high-density lipoprotein cholesterol (HDL).

Many of the patients seen have already been diagnosed as having lipid disorders, diabetes (adult onset type II diabetes) and/or vascular problems; our primary goal for those patients is to prevent subsequent vascular problems. For patients in earlier stages of their disease, we provide treatment to prevent development of vascular problems.

In addition to diagnostic testing, our endocrinologists perform fine needle aspiration of thyroid nodules to identify the small proportion of nodules that are cancerous.

The vast majority of our patients are referred by other physicians. However, a self referral may be accepted by an individual endocrinologist and is subject to that physician's review.

The diagnostic procedures by Washington University Physicians are extensive, with each patient receiving an in-depth assessment of the medical problem. Our laboratory has very high quality control standards and performs the specialized tests not routinely done at other locations. In fact, our Core Laboratory for Clinical Studies performs measurements for the national Centers for Disease Control (CDC) as part of a network that provides quality control for other labs throughout the United States.

All of the physicians are certified by the American Board of Internal Medicine in the subspecialty of endocrinology, diabetes and metabolism. This group is an important resource for the diagnosis and treatment of unusual and/or very difficult cases.

Read the original post:
Endocrinology | Endocrinology Services St Louis Missouri ...

Read More...

Research | Division of Endocrinology

September 6th, 2015 7:44 am

Faculty in the Division of Endocrinology are the principal investigators or co-investigators in nationally recognized, basic and clinical research projects funded by the National Institutes of Health (NIH), the Centers for Disease Control (CDC), national foundations and industry. In 2012 the extramural research support for the division was $1,370,086 (Grants $1,220,631 and Industry $149,455).

Clinical research interests of the faculty include: growth with an emphasis on IGF; Turners syndrome ; metabolic bone disease; the side effects of atypical anti-psychotics; beta cell function in type 2 diabetes; carbohydrate metabolism and bone disease in cystic fibrosis; endocrine disorders associated with childhood cancer survivors; Duchennes muscular dystrophy; disorders of sexual differentiation; toddler obesity; septo-optic dysplasia; the natural history of obesity, insulin resistance and diabetes in adolescents; the epidemiology of types of diabetes; and the natural history and mechanisms of the development of cardiovascular disease in childhood obesity and diabetes.

Basic science research interests of the faculty include the role and control of inflammation in metabolic diseases, placental decidualization, the development of the enteroendocrine system, the development and function of the beta cell, and the development of autoimmune diabetes.

The Diabetes Center is dedicated to providing the highest level of comprehensive care to patients diagnosed with diabetes. The diabetes team seeks to advance medical treatment and diabetes prevention through patient care, education and research. Learn more about the Diabetes Center.

See the article here:
Research | Division of Endocrinology

Read More...

Endocrinology & Metabolism Department of Medicine

September 6th, 2015 7:44 am

The major purpose of the division is to provide teaching, research and patient care in all aspects of endocrinology and metabolism. Our primary goals are to provide new knowledge as to how hormones work and how their actions are altered in disease states and to improve the quality of patient care in endocrinology and metabolism by conducting high quality and informative teaching as well as providing best possible expertise in consultative care.

We provide primary and consultative care for patients with diabetes, hypertension and lipid disorders and we provide consultative care for all aspects of endocrinology and metabolism to both inpatients and outpatients.

Our research involves both clinical and basic science investigation. We are focused on mechanisms of insulin resistance, new modalities for treatment of diabetes, factors that are responsible for improving bone mineral density, the role of hormones in reproductive disorders in women, molecular mechanisms of obesity and the role of hormones in the development of atherosclerosis.

Our teaching responsibilities include students in the Graduate School and the School of Medicine as well as providing continuing education for physicians throughout the state of North Carolina.

Chief and Professor Division of Endocrinology

HOW TO GET AN APPOINTMENT? The UNC Hospitals Diabetes & Endocrinology Clinic at Meadowmont are a subspecialty clinic. That means that our doctors and staff of Endocrinology are not set up to act as primary care doctors for their patients. It also means that in general, we prefer to see patients referred by other physicians. If you do not have a primary care provider, we can help you find one. For appointments, inquiries about appointment times, to reschedule or cancel an appointment, please call the UNC Hospitals Diabetes & Endocrine Clinic at Meadowmont scheduling line at (984)974-2950. Fax (984) 974-2924

Read more from the original source:
Endocrinology & Metabolism Department of Medicine

Read More...

Adult Stem Cell Therapy Tackles Diabetes Complications …

September 5th, 2015 5:47 am

By: Brenda Neugent

By Brenda Neugent

Despite a degree of controversy surrounding stem cell therapy, more scientists are starting to discover that adult stem cells are like tiny superheroes with the potential to ease the symptoms of a multitude of serious health problems.

Among the most effective uses for stem cells include inflammation-based diseases such as type 2 diabetes as well as autoimmune disorders like type 1 diabetes and rheumatoid arthritis.

Traditionally, the disease and its complication are treated with insulin as well as drugs that help reduce pain, protect organs and prevent additional damage by helping regulate blood glucose levels.

Adult stem cell therapy removes a patients stem cells stored in body fat and injects them into the abdomen where the majority of the immune system lives and helps treats most of the complications associated with diabetes.

Stem cells are like a small but powerful medical team, according to Dr. Todd Malan, the chief cell therapy at Okyanos, one of the leaders in stem cell technology. They are blank slates that can serve a wide range of purposes, including:

Repairing the lining of blood vessels so blood flows more smoothly. Because they increase blood flow, stem cells can also reverse damage to the beta cells of the pancreas tasked with making insulin, so there is more of the hormone available naturally; Improving the communication between cells, so cells are better able to take in glucose, reducing the amount of sugar in the blood; Restoring nerve function, so the pain of peripheral neuropathy is reduced; and Alleviating inflammation, lessening stress on the body and reducing the release of abnormal levels of inflammatory messengers.

Once the stem cells enter the body, they immediately realize where the bodys inflammation exists and heads there to fix it. This includes tissue repair, the creation of new blood vessels, building cartilage or muscles to fix the damage.

Adult stem cells can reverse, prevent and slow down much of the damage caused by high blood sugar levels.

Stem cells from your body are much better at the cell to cell communication, said Malan, and immediately realize they have a lot of jobs to do.

comments

See the article here:
Adult Stem Cell Therapy Tackles Diabetes Complications ...

Read More...

Personalized Medicine Conferences | Europe | Worldwide …

September 5th, 2015 5:47 am

OMICS Internationalinvites all the participants across the globe to attend 3rd International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics during September 01-03, 2015 Valencia, Spain.

Personalized Medicine 2015scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies in Personalized Medicine.

OMICS Internationalis devotedly involved in conducting International conferences 2014-2015 Europe, across USA (Baltimore, Chicago, Las Vegas, Philadelphia, and San Antonio) and almost all other parts of the world

Personalized Medicine 2015 will serve as an impulse for the advancement of molecular analysis by connecting scientists all across the world at conferences and exhibitions that would create an environment conducive for information exchange, generation of new ideas and acceleration of applications. Personalized Medicine promises many medical innovations, and has the potential to change the way treatments are discovered and used.

Personalized Medicine is referred as individualized therapy which means the prescription of specific treatments and therapeutics. Biomarker is a biological characteristic which can be molecular, anatomic, physiologic and chemical change drug development research which turns biomarkers into companion diagnostics. Personalized medicine therapeutics and companion diagnostic market have huge opportunities for growth in healthcare and will improve therapeutic effectiveness and reduce the severity of adverse effects approach to drug therapies. Personalized cancer medicine is self-made samples of translating cancer genetics into medical. Genomic medicine can contribute to personalized medicine Genomics by revealing genomic variations; have an effect on health, sickness and drug response.

Please, submit your abstract according to our format as early as possible and take advantage of early bird registration. All abstracts will be reviewed by the OCM/Review Panel.

As the hardest problem with science can only be solved by the Opencollaboration with Scientifc Community, Series of Conferences are Organized by Omics International Confereses, for more details have a glance atConference Series

Track 1:Current Focus on Personalized Medicine

Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease. Knowledge of a patient's genetic profile can help doctors select the proper medication or therapy and administer it using the proper dose or regimen. Used for the treatment asPersonalized cancer medicine,Diabetes- related disease: risk assessment & management,Personalized medicine: New strategies and economic implications,Implications of personalized medicine in treatment of HIV,Applications of personalized medicine in rare diseases,Translational Medicine.

Track 2:Clinical aspects of Personalized Medicine in Human, Animal models

Personalized medicine is based on intraspecies differences. It is axiomatic that small differences in genetic make-up can result in dramatic differences in response to drugs or disease andSocietal impact of personalized medicine. To express this in more general terms: in any given complex system, small changes in initial conditions can result in dramatically different outcomes. Despite human variability and intraspecies variation in other species, nonhuman species are still the primary model for ascertaining data forPersonalized medicine health improvement in Human.We call this practice into question and conclude that human-based research should be the primary means for obtaining data about human diseases and responses to drugs.Strategies in the development and application of personalized medicinewas developed for the accurate results inPersonalized medicine health improvement in Human and Animal Models.

Track 3:Genetics of Ebola Outbreak

Sequence analysis of Ebola virus Genomeis the second through the sixth genes of the Ebola virus (EBO) genome indicates that it is organized similarly to rhabdoviruses and paramyxoviruses and is virtually the same as Marburg virus (MBG). Scientists usedgenomic sequencing technologiesto identify the origin and track transmission of the Ebola virus in the current outbreak in Africa.

Track 4:Molecular Diagnostics and Therapeutics

Molecular diagnosticsis a technique used to analyzebiological markersin thegenomeandproteome,realizing the value of personalized medicinethe individual'sgenetic codeand how their cells express their genes asproteins, by applyingmolecular biologytomedical testing. The technique is used to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients.Therapeutics and diagnosticsare useful in a range of medical specialisms, includinginfectious disease,oncology,human leukocyte antigentyping (which investigates and predictsimmune function),coagulation, and pharmacogenomicsthe genetic prediction of which drugs will work best and even leads totranslational research.

Track 5:Biomarkers

In medicine, abiomarkerand molecular markersare the measurableindicatorof the severity or presence of some disease state. More generally abiomarkeris anything that can be used as an indicator of a particular disease state or some otherphysiologicalstate of an organismDrug-Diagnostic Co-Development. In the current era of stratified medicine and biomarker-driven therapies, the focus has shifted from predictions based on the traditional anatomic staging systems to guide the choice of treatment for an individual patient to an integrated approach using the genetic makeup of the tumor and the genotype of the patient. Genomics and other "omics technologies have largely contributed to the identification and the development of biomarkers likeStratification biomarkers in personalised medicine. The recent surge in high-throughput sequencing of cancer genomes has supported an expanding molecular classification of cancer. These studies have identified putative predictive biomarkers signifying aberrant oncogene pathway activation and may provide a rationale for matching patients with molecularly targeted therapies in clinical trials. Here, we discuss some of the challenges of adapting these data for rare cancers or molecular subsets of certain cancers, which will require aligning the availability of investigational agents, rapid turnaround of clinical grade sequencing, molecular eligibility and reconsideringPersonalizing clinical trials with biomarkersdesign and end points.

Track 6:Nanotechnology and Biotechnology

Nanotechnology("nanotech") is the manipulation of matter on anatomic,molecular, and supramolecularscale. The earliest, widespread description of nanotechnologyreferred to the particular technological goal of precisely manipulating atoms and molecules for fabrication of macroscale products, also now referred to asmolecular nanotechnology. Applications of pharmaceutical nanotools,Cell based therapy,Molecular mechanismsare the techniques and tool in nano technology and biotechnology.

The human metabolome is best understood by analogy to the human genome, i.e., where the human genome is the set of all genes in a human being, the human metabolome is the set of all metabolites in a human being well understood by Role of Metabolics, Bioinformatics, Biosensorsin Personalized Medicine.

Track 7:Predictive Medicine in Pharmaceutical Analysis

Predictive medicineis a field ofmedicinethat entails predicting the probability ofdiseaseand instituting preventive measures in order to either prevent the disease altogether or significantly decrease its impact upon the patient (such as by preventingmortalityor limitingmorbidity).Techniques and assaysincludeNewborn screening,Diagnostic testing,Medical bioinformatics,Prenatal testing,Carrier testing,Preconception testing. Newborn screeningis apublic healthprogram designed to screen infants shortly after birth for a list of conditions that are treatable, but not clinically evident in the newborn period.Prenatal testing: Prenatal testing is used to look for diseases and conditions in a fetus orembryobefore it is born. This type of testing is offered for couples who have an increased risk of having a baby with a genetic or chromosomal disorder. Screening can determine the sex of the fetus.Prenatal testingcan help a couple decide whether toabortthe pregnancy. Like diagnostic testing,prenatal testingcan be noninvasive or invasive. Non-invasive techniques include examinations of the woman's womb throughor maternal serum screens. These non-invasive techniques can evaluate risk of a condition, but cannot determine with certainty if the fetus has a condition.

Track 8:Preventive Medicine

Preventive Medicine is practiced by all physicians to keep their patients healthy. It is also a unique medical specialty recognized by the American Board of Medical Specialties (ABMS). Preventive Medicinefocuses on the health of individuals, communities, and defined populations. It is also used for the treatment forobesity, blindness. TheEpidemiologyDivisionapplies research methods to understand the patterns and causes of health and disease in the populationandto translate this knowledge into programs designed to prevent disease. The division has a long history of involvement in NIH-sponsored multi-site, longitudinal cohort studies, and its faculty oversees many investigator-initiated, NIH-sponsored research projects and trials. Public trust invaccinesis a key to the success of immunization programs worldwide in the era of preventive medicine.

Track 9:Health Care Medicine and P4 Medicine

P4 Medicineis a plan to radically improve the quality of human life via biotechnology. P4 Medicine is a term coined by biologist Leroy Hood, and is short for "Predictive, Preventive, Personalized, andParticipatory Medicine." The premise of P4 Medicine is that, over the next 20 years, medical practice will be revolutionized by biotechnology, to manage a person's health, instead of manage a patient's disease.Internal medicineorgeneralmedicine(in Commonwealth nations) is themedicalspecialty dealing with the prevention, diagnosis, and treatment of adult diseases.Emergency medicineis amedicalspecialty involving care for adult and pediatric patients with acute illnesses or injuries that require immediatemedicalattention.

Track 10:Lifestyle Medicine

Lifestyle Medicine (LM) is the use of lifestyle interventions in the treatment andmanagement of disease. LM is becoming the preferred modality for not only the prevention but thetreatment of most chronic diseases, including Type-2 Diabetes, Coronary Heart Disease, Hypertension, Obesity, Insulin Resistance Syndrome, Osteoporosis, cancer prevention Alsoinclude Aerobic & Resistance exercises for patients with diabetes,Sleep and disease prevention, Intrinsic motivation and health behavior adherence.

Track 11:Genomics

Genomicsis a discipline ingeneticsthat appliesrecombinant DNA,DNA sequencingmethods, andbioinformaticsto sequence, assemble, and analyze the function and structure ofgenomes. Advances in genomics have triggered a revolution in discovery-based research to understand even the most complex biological systems such as the brain. The field includes efforts to determine the entireDNA sequenceandhuman genome varivationof organisms and fine-scalegenetic mapping. The field also includes studies of intragenomic phenomena such as other interactions betweenlociand within thegenome and metagenomics.Comparative genomicsis an exciting new field of biological research in which thegenomesequences of different species human, mouse and a wide variety of other organisms from yeast to chimpanzees are compared.

Track 12:Cancer Immunology & Oncology

Personalized medicine can be used to learn about a person's genetic makeup and to unravel thebiology of their tumor. Using this information, doctors hope to identify prevention, screening, andtreatment strategiesthat may be more effective and cause fewer side effects than would be expected with standard treatments. By performing more genetic tests and analysis, doctors may customize treatment to each patient's needs. Creating a personalized cancer screening and treatment plan includes: Determining the chances that a person will develop cancer and selectingscreening strategiesto lower the risk, Matching patients with treatments that are more likely to be effective and cause fewer side effects,Predicting the risk of recurrence(return of cancer).

Personalized medicine can be used to learn about a person's genetic makeup and to unravel the biology of their tumor. Using this information, doctors hope to identify prevention, screening, and treatment strategies that may be more effective and cause fewer side effects than would be expected with standard treatments. By performing more genetic tests and analysis, doctors may customize treatment to each patient's needs. Creating aPersonalized Cancer Medicineand treatment plan includes: Determining the chances that a person will develop cancer and selecting screeningstrategies to lower therisk, Matching patients with treatments that are more likely to be effectiveand cause fewer side effects, Predicting the risk of recurrence(return of cancer).

Personalized medicine is an evolving field of medicine in which treatments are tailored to the individual patient.Personalized Diagnosticsare medical devices that help doctors decide which treatments to offer patients and which dosage to give, tailored specifically to the patient, says Elizabeth A. Mansfield, Ph.D., Deputy Office Director for Personalized Medicine in FDAs Office of In Vitro Diagnostics and Radiological Health. The companion diagnostic is essential to the safe and effective use of the drug.

Personalized Medicine Diabetesis the use of information about the genetic makeup of a person with diabetes to tailor strategies for preventing, detecting, treating, or monitoring their diabetes. The practice of PMFD involves four processes. First is the identification of genes and biomarkers for diabetes as well as for obesity. Second, is allocation of resources to prevent or detect the diabetes and/or obesity phenotype in high-risk individuals, whose risk is based on their genotype. Third is selection of individualized therapies for affected individuals. Fourth is measurement of circulating biomarkers of diabetes to monitor the response to prevention or therapy.

Personalized Medicine World Conferencewill serve as an impulse for the advancement of molecular analysis by connecting scientists all across the world at conferences and exhibitions that would create an environment conducive for information exchange, generation of new ideas and acceleration of applications.Personalized Medicine Conferencepromises many medical innovations, and has the potential to change the way treatments are discovered and used.

Cancer chemotherapy is in evolution from non-specific cytotoxic drugs that damage both tumour and normal cells to more specific agents and immunotherapy approaches. Targeted agents are directed at unique molecular features of cancer cells, and immunotherapeutics modulate the tumour immune response; both approaches aim to produce greater effectiveness with less toxicity. The development and use of such agents in biomarker-defined populations enables a morePersonalized Medicine Oncologytreatment than previously possible and has the potential to reduce the cost of cancer care.

The term "personalized medicine" is often described as providing "the right patient with the right drug at the right dose at the right time." More broadly,personalized medicine(also known asprecision medicine)may be thought of as the tailoring of medical treatment to the individual characteristics, needs, and preferences of a patient during all stages of care, including prevention, diagnosis, treatment, and follow-up. International expertise Gathering onPersonalized Medicine World Congress.

Personalized medicine will shift medical practices upstream from the reactive treatment of disease, to proactive healthcare management including screening, early treatment, and prevention, and will alter the roles of both physician and patient. Personalized medicine requires a systems approach to implementation. But in a healthcare economy that is highly decentralized and market driven, it is incumbent upon the stakeholders themselves to advocate for a consistent set of policies and legislation that pave the way for the adoption of personalized medicine. To address this need, thePersonalized Medicine Coalition(PMC) was formed as a nonprofit umbrella organization of pharmaceutical, biotechnology, diagnostic, and information technology companies, healthcare providers and payers, patient advocacy groups, industry policy organizations, major academic institutions, and government agencies.

Pharmacogenomics is part of a field called personalized medicine, also called individualized or precision medicine, that aims to customize health care, with decisions and treatments tailored to each individual patient in every way possible.Although genomic testing is still a relatively new development in drug treatment, this field is expanding. Currently, more than 100 drugs have label information regardingPersonalized Medicine Pharmacogenomicsbiomarkers some measurable or identifiable segment of genetic information that can be used to direct the use of a drug.

Advances in human genome research are opening the door to a new paradigm for practicing medicine that promises to transform healthcare. Personalized medicine, the use of marker-assisted diagnosis and targeted therapies derived from an individual's molecular profile, will impact the way drugs are developed and medicine is practiced. The traditional linear process of drug discovery and development will be replaced by an integrated and heuristic approach. In addition,Personalized Medicine Patient Carewill be revolutionized through the use of novel molecular predisposition, screening, diagnostic, prognostic, pharmacogenomic and monitoring markers. Although numerous challenges will need to be met to make personalized medicine a reality, with time, this approach will replace the traditional trial-and-error practice of medicine.

Personalized lifestyle medicine is a newly developed term that refers to an approach to medicine in which an individual's health metrics from point-of-care diagnostics are used to develop lifestyle medicine-oriented therapeutic strategies for improving individual health outcomes in managing chronic disease.Personalized lifestyle medicinecan provide solutions to chronic health problems by harnessing innovative and evolving technologies based on recent discoveries in genomics, epigenetics, systems biology, life and behavioral sciences, and diagnostics and clinical medicine.

The US market for personalized medicines is predicted to grow at the compounded annual growth rate of 9.5% during 2010 to 2015. This growth in future is expected to be driven by different factors like cost savings on treatments, early diagnosis of disease, drug safety, patient compliance, and optimization of therapies. Currently, America dominates the market for personalized medicine; however, advancement in technology and developments in the field of DNA is expected to establishPersonalized Medicine Marketin UK, France, India, China, and Japan.

Rapid advances in technology have made it feasible to identify a persons unique genome. One person differs from another by millions of variations in the genome, and many of these variations affect susceptibility to disease and response to treatments.Greater understanding of individual genomes is allowing scientists and clinicians to begin to personalize" medicine. ThePersonalized Genomic Medicinerevolution will yield more effective medicines with fewer adverse side effects and lead to longer, healthier lives and lower health care costs. The personalized medicine industry in the United States already generates $286 billion per year in revenues and is growing by 11 percent annually, according to PricewaterhouseCoopers.Research at JAX Genomic Medicine will contribute to personalized medicine by revealing how genomic variations affect health, disease and drug response.

The globalPersonalized Medicine Industrywas valued at USD 1,007.88 billion in 2014 and is expected to reach USD 2,452.50 billion in 2022, growing at a CAGR of 11.8% over the forecast period. Key drivers of the market include growing development of next generation sequencing, whole genome technology, companion diagnostics and growing number of retail clinics.

Excerpt from:
Personalized Medicine Conferences | Europe | Worldwide ...

Read More...

The Stem Cell Debate: Is it over? – Learn Genetics

September 4th, 2015 5:48 am

HOME

Stem Cells

The Stem Cell Debate: Is It Over?

Stem cell therapies are not new. Doctors have been performing bone marrow stem cell transplants for decades. But when scientists learned how to remove stem cells from human embryos in 1998, both excitement and controversy ensued.

The excitement was due to the huge potential these cells have in curing human disease. The controversy centered on the moral implications of destroying human embryos. Political leaders began to debate over how to regulate and fund research involving human embryonic stem (hES) cells.

Newer breakthroughs may bring this debate to an end. In 2006 scientists learned how to stimulate a patient's own cells to behave like embryonic stem cells. These cells are reducing the need for human embryos in research and opening up exciting new possibilities for stem cell therapies.

Both human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells are pluripotent: they can become any type of cell in the body. While hES cells are isolated from an embryo, iPS cells can be made from adult cells.

Until recently, the only way to get pluripotent stem cells for research was to remove the inner cell mass of an embryo and put it in a dish. The thought of destroying a human embryo can be unsettling, even if it is only five days old.

Stem cell research thus raised difficult questions:

With alternatives to hES cells now available, the debate over stem cell research is becoming increasingly irrelevant. But ethical questions regarding hES cells may not entirely go away.

For now, some human embryos will still be needed for research. iPS cells are not exactly the same as hES cells, and hES cells still provide important controls: they are a gold standard against which the "stemness" of other cells is measured.

Some experts believe it's wise to continue the study of all stem cell types, since we're not sure yet which one will be the most useful for cell replacement therapies.

An additional ethical consideration is that iPS cells have the potential to develop into a human embryo, in effect producing a clone of the donor. Many nations are already prepared for this, having legislation in place that bans human cloning.

Regulations and policies change frequently to keep up with the pace of research, as well as to reflect the views of different political parties. Here President Obama signs an executive order on stem cells, reversing some limits on federal research funding. (White House photo by Chuck Kennedy)

Governments around the globe have passed legislation to regulate stem cell research. In the United States, laws prohibit the creation of embryos for research purposes. Scientists instead receive "leftover" embryos from fertility clinics with consent from donors. Most people agree that these guidelines are appropriate.

Disagreements surface, however, when political parties debate about how to fund stem cell research. The federal government allocates billions of dollars each year to biomedical research. But should taxpayer dollars be used to fund embryo and stem cell research when some believe it to be unethical? Legislators have had the unique challenge of encouraging advances in science and medicine while preserving a respect for life.

U.S. President Bush, for example, limited federal funding to a study of 70 or so hES cell lines back in 2001. While this did slow the destruction of human embryos, many believe the restrictions set back the progress of stem cell research.

President Obama overturned Bush's stem cell policy in 2009 to expand the number of stem cell lines available to researchers. Policy-makers are now grappling with a new question: Should the laws that govern other types of pluripotent stem cells differ from those for hES cells? If so, what new legislation is needed?

APA format: Genetic Science Learning Center (2014, June 22) The Stem Cell Debate: Is It Over?. Learn.Genetics. Retrieved September 04, 2015, from http://learn.genetics.utah.edu/content/stemcells/scissues/ MLA format: Genetic Science Learning Center. "The Stem Cell Debate: Is It Over?." Learn.Genetics 4 September 2015 <http://learn.genetics.utah.edu/content/stemcells/scissues/> Chicago format: Genetic Science Learning Center, "The Stem Cell Debate: Is It Over?," Learn.Genetics, 22 June 2014, <http://learn.genetics.utah.edu/content/stemcells/scissues/> (4 September 2015)

Read the original here:
The Stem Cell Debate: Is it over? - Learn Genetics

Read More...

What is Biotechnology?

September 4th, 2015 5:44 am

Forty years ago, viable monoclonal antibodies, imperceptibly small magic bullets, became available for the first time. First produced in 1975 by Csar Milstein and Georges Khler at the Laboratory of Molecular Biology in Cambridge, England (where Watson and Crick unraveled the structure of DNA), Mabs have had a phenomenally far-reaching effect on our society and daily life. The Lock and Key of Medicine is the first book to tell the extraordinary yet unheralded history of monoclonal antibodies, or Mabs. Though unfamiliar to most nonscientists, these microscopic protein molecules are everywhere, quietly shaping our lives and healthcare. They have radically changed understandings of the pathways of disease, enabling faster, cheaper, and more accurate clinical diagnostic testing. And they lie at the heart of the development of genetically engineered drugs such as interferon and blockbuster personalized therapies such as Herceptin.

Historian of medicine Lara V. Marks recounts the risks and opposition that a daring handful of individuals faced while discovering and developing Mabs, and she addresses the related scientific, medical, technological, business, and social challenges that arose. She offers a saga of entrepreneurs who ultimately changed the healthcare landscape and brought untold relief to millions of patients. Even so, controversies over Mabs remain, which the author explores through the current debates on their cost-effectiveness.

Read the original here:
What is Biotechnology?

Read More...

arthritis | disease | Britannica.com

September 3rd, 2015 1:44 pm

Arthritis,inflammation of the joints and its effects. Arthritis is a general term, derived from the Greek words arthro-, meaning joint, and -itis, meaning inflammation. Arthritis can be a major cause of disability. In the United States, for example, data collected from 2007 to 2009 indicated that 21 million adults were affected by arthritis and experienced limited activity as a result of their condition. Overall, the incidence of arthritis was on the rise in that country, with 67 million adults expected to be diagnosed by 2030. Likewise, each year in the United Kingdom, arthritis and related conditions caused more than 10 million adults to consult their doctors. Although the most common types of arthritis are osteoarthritis and rheumatoid arthritis, a variety of other forms exist, including those secondary to infection and metabolic disturbances.

Osteoarthritis, also known as degenerative joint disease, is the most common form of arthritis, affecting nearly one-third of people over age 65. It is characterized by joint pain and mild inflammation due to deterioration of the articular cartilage that normally cushions joints. Joint pain is gradual in onset, occurring after prolonged activity, and is typically deep and achy in nature. One or multiple joints may be affected, predominantly involving the knee, hips, spine, and fingers.

Approximately 90 percent of individuals experience crepitus (crackling noises) in the affected joint with motion. Muscle weakness and joint laxity or stiffness can occur as people become reluctant to move painful joints. Patients tend to have decreased joint stability and are predisposed to injuries such as meniscal and anterior cruciate ligament tears. Hip arthritis can affect gait, while arthritis of the hands can lead to decreased dexterity. Enlargement of the bony processes surrounding affected joints, called osteophytes (bone spurs), are common.

Joint trauma, increased age, obesity, certain genetic factors and occupations, and hobbies or sports that result in excessive joint stresses can result in the cartilaginous changes leading to osteoarthritis. Damage begins with the development of small cracks in the cartilage that are perpendicular to the joint. Eventually, cartilage erodes and breaks off, facilitating painful bone-on-bone contact. In due course, pathologic bony changes, such as osteophytes and subchondral bone cysts, develop and further restrict joint movement and integrity.

Osteoarthritis may be divided into two types, primary and secondary osteoarthritis. Primary osteoarthritis is age-related, affecting 85 percent of individuals 7579 years of age. Although the etiology is unknown, primary osteoarthritis is associated with decreased water-retaining capacity in the cartilage, analogous to a dried-up rubber band that can easily fall apart. Secondary osteoarthritis is caused by another condition, such as joint trauma, congenital joint malalignment, obesity, hormonal disorders, and osteonecrosis. Treatment for osteoarthritis is directed toward reducing pain and correcting joint mechanics and may include exercise, weight loss, nonsteroidal anti-inflammatory drugs, steroids, and total joint replacement surgery.

Autoimmune arthritis is characterized by joint inflammation and destruction caused by ones own immune system. Genetic predisposition and inciting factors, such as an infection or trauma, can trigger the inappropriate immune response. Rheumatoid arthritis, which is an autoimmune disease, is often associated with elevations in the serum level of an autoantibody called rheumatoid factor, whereas the seronegative arthropathies are not.

Rheumatoid arthritis is a progressive inflammatory condition that can lead to decreased mobility and joint deformities. The worldwide prevalence is 0.8 percent, with a 2:1 predilection for women over men. Disease onset, mainly occurring in the third and fourth decades of life, may be acute or slowly progressive with initial symptoms of fatigue, weakness, malaise, weight loss, and mild, diffuse joint pain. Rheumatoid arthritis tends to affect the hips, knees, elbows, ankles, spine, hands, and feet symmetrically. The disease course is characterized by periods of remission, followed by progressive exacerbations in which specific joints become warm, swollen, and painful. Morning stiffness, typically lasting about two hours, is a hallmark feature of rheumatoid arthritis. Patients with rheumatoid arthritis tend to complain of joint pain after prolonged periods of inactivity, whereas osteoarthritis is typically exacerbated with extended activity. Rheumatoid arthritis can be severely debilitating, resulting in a variety of deformities. Some patients experience complete remission, which typically occurs within two years of disease onset.

Although the exact cause is unknown, rheumatoid arthritis results from the inflammation of the tissues surrounding the joint space. The thin lining of the joint space becomes thick and inflamed, taking on the form of a mass with fingerlike projections (pannus), which invades the joint space and surrounding bone. Initially, this results in joint laxity. However, with progression, the bones can actually undergo fusion (ankylosis), limiting motion.

The effect rheumatoid arthritis has on the hands is a defining characteristic. Clinically, it can be distinguished from osteoarthritis based on the distribution of joints affected in the hands. Rheumatoid arthritis tends to affect the more proximal joints, whereas osteoarthritis tends to affect the more distal joints of the hands and fingers. In severe cases, joint laxity and tendon rupture result in a characteristic deformity of the fingers and wrist.

Rheumatoid nodules are thick fibrous nodules that form as a result of excessive tissue inflammation in rheumatoid arthritis. These nodules are typically present over pressure points, such as the elbows, Achilles tendon, and flexor surfaces of the fingers. Destruction of peripheral blood vessels (vasculitis) from the inflammatory process can occur in any organ, leading to renal failure, myocardial infarction (heart attack), and intestinal infarction (death of part of the intestine). In addition, rheumatoid arthritis is also associated with an increased risk of infections, osteoporosis (thinning of bones), and atherosclerosis (hardening of arteries).

Diagnosis of rheumatoid arthritis is based on the presence of several clinical features: rheumatoid nodules, elevated levels of rheumatoid factor, and radiographic changes. Although rheumatoid factor is found in 70 to 80 percent of people with rheumatoid arthritis, it cannot be used alone as a diagnostic tool, because multiple conditions can be associated with elevated levels of rheumatoid factor.

Since no therapy cures rheumatoid arthritis, treatment is directed toward decreasing symptoms of pain and inflammation. Surgical treatment may include total joint replacement, carpal tunnel release (cutting of the carpal ligament), and tendon repair. Hand splints are used to slow the progression of finger and wrist deformations.

The overall life span of individuals with rheumatoid arthritis is typically shortened by 510 years and is highly dependent on disease severity. Disease severity and the likelihood of extra-articular manifestations are each directly related to serum rheumatoid factor levels.

Several rheumatoid arthritis variants exist. In Sjgren syndrome the characteristic symptoms include dry eyes, dry mouth, and rheumatoid arthritis. Felty syndrome is associated with splenomegaly (enlarged spleen), neutropenia (depressed white blood cell levels), and rheumatoid arthritis. Juvenile rheumatoid arthritis is the most common form of childhood arthritis. Disease etiology and clinical course typically differ from that of adult-onset rheumatoid arthritis, and sufferers are prone to the development of other rheumatologic diseases, including rheumatoid arthritis.

Ankylosing spondylitis, Reiter syndrome, psoriatic arthritis, and arthritis associated with inflammatory bowel disease are a subset of conditions known as spondyloarthropathies. Typically affected are the sacrum and vertebral column, and back pain is the most common presenting symptom. Enthesitis, inflammation at the insertion of a tendon or ligament into bone, is a characteristic feature of spondyloarthropathy. Unlike rheumatoid arthritis, spondyloarthropathies are not associated with elevated levels of serum rheumatoid factor. Spondyloarthropathies occur most frequently in males and in individuals with a genetic variation known as HLA-B27.

Ankylosing spondylitis is the most common type of spondyloarthropathy, affecting 0.1 to 0.2 percent of the population in the United States. In a region of Turkey, prevalence was found to be 0.25 percent, and in the United Kingdom prevalence is estimated to range from 0.1 to 2 percent. In all regions, the condition occurs more frequently in males than in females and typically strikes between ages 15 and 40. Genetic studies have shown that more than 90 percent of all patients with ankylosing spondylitis who are white and of western European descent are HLA-B27 positive.

Ankylosing spondylitis is characterized by arthritis of the spine and sacroiliac joints. Extensive inflammation of the spinal column is present, causing a characteristic bamboo spine appearance on radiographs. Arthritis first occurs in the sacroiliac joints and gradually progresses up the vertebral column, leading to spinal deformity and immobility. Typical symptoms include back pain, which lessens with activity, and heel pain due to enthesitis of the plantar fascia and Achilles tendon. Hip and shoulder arthritis may occur early in the course of the disease.

Reiter syndrome, a type of reactive arthritis, is characterized by the combination of urethritis, conjunctivitis, and arthritis. Patients typically develop acute oligoarthritis (two to four joints affected) of the lower extremities within weeks of gastrointestinal infection or of acquiring a sexually transmitted disease. Reiter arthritis is not considered an infectious arthritis, because the joint space is actually free of bacteria. Instead, an infection outside the joint triggers this form of arthritis. Other symptoms can include fever, weight loss, back pain, enthesitis of the heel, and dactylitis (sausage-shaped swelling of the fingers and toes). Most cases resolve within one year; however, 1530 percent of patients develop chronic, sometimes progressive arthritis. Occurring almost exclusively in men, Reiter syndrome is strongly linked to the HLA-B27 gene variant, which is present in 65 to 96 percent of symptomatic individuals.

Psoriasis is an immune-mediated inflammatory skin condition characterized by raised red plaques with an accompanying silvery scale, which can be painful and itchy at times. Though typically seen on the elbow, knees, scalp, and ears, plaques can occur on any surface of the body. About 10 percent of people with psoriasis (possibly as many as 30 percent in some regions of the world) develop a specific type of arthritis known as psoriatic arthritis.

Psoriatic arthritis typically occurs after psoriasis has been present for many years. In some cases, however, arthritis may precede psoriasis; less often, the two conditions appear simultaneously. Estimates on the prevalence of psoriatic arthritis vary according to population. However, overall, it is thought to affect nearly 1 percent of the general population, with a peak age of onset between 30 and 55. Usually less destructive than rheumatoid arthritis, psoriatic arthritis tends to be mild and slowly progressive, though certain forms, such as arthritis mutilans, can be quite severe. Occasionally the onset of symptoms associated with psoriatic arthritis is acute, though more often it is insidious, initially presenting as oligoarthritis with enthesitis. Over time, arthritis begins to affect multiple joints (polyarthritis), especially the hands and feet, resulting in dactylitis. Typically, the polyarticular pattern of psoriatic arthritis affects a different subset of finger joints than rheumatoid arthritis. It is not until years after peripheral arthritis has occurred that psoriatic arthritis may affect the axial joints, causing inflammation of the sacroiliac joint (sacroiliitis) and intervertebral joints (spondylitis).

Arthritis mutilans is a more severe and much less common pattern (seen in fewer than 5 percent of psoriatic arthritis cases) resulting in bone destruction with characteristic telescoping of the fingers or toes. In addition, individuals with psoriatic arthritis necessitate more aggressive treatment if the onset of the condition occurs before age 20, if there is a family history of psoriatic arthritis, if there is extensive skin involvement, or if the patient has the HLA-DR4 genotype.

Crohn disease and ulcerative colitis, two types of inflammatory bowel disease, are complicated by a spondyloarthropathy in as many as 20 percent of patients. Although arthritis associated with inflammatory bowel disease typically occurs in the lower extremities, up to 20 percent of cases demonstrate symptoms identical to ankylosing spondylitis. Arthritis is usually exacerbated in conjunction with inflammatory bowel disease exacerbations and lasts several weeks thereafter.

Joint inflammation, destruction, and pain can occur as a result of the precipitation of crystals in the joint space. Gout and pseudogout are the two primary types of crystalloid arthritis caused by different types of crystalloid precipitates.

Gout is an extremely painful form of arthritis that is caused by the deposition of needle-shaped monosodium urate crystals in the joint space (urate is a form of uric acid). Initially, gout tends to occur in one joint only, typically the big toe (podagra), though it can also occur in the knees, fingers, elbows, and wrists. Pain, frequently beginning at night, can be so intense that patients are sensitive to even the lightest touch. Urate crystal deposition is associated with the buildup of excess serum uric acid (hyperuricemia), a by-product of everyday metabolism that is filtered by the kidneys and excreted in the urine. Causes of excess uric acid production include leukemia or lymphoma, alcohol ingestion, and chemotherapy. Kidney disease and certain medications, such as diuretics, can depress uric acid excretion, leading to hyperuricemia. Although acute gouty attacks are self-limited when hyperuricemia is left untreated for years, such attacks can recur intermittently, involving multiple joints. Chronic tophaceous gout occurs when, after about 10 years, chalky, pasty deposits of monosodium urate crystals begin to accumulate in the soft tissue, tendons, and cartilage, causing the appearance of large round nodules called tophi. At this disease stage, joint pain becomes a persistent symptom.

Gout is most frequently seen in men in their 40s, due to the fact that men tend to have higher baseline levels of serum uric acid. In the early 21st century the prevalence of gout appeared to be on the rise globally, presumably because of increasing longevity, changing dietary and lifestyle factors, and the increasing incidence of insulin-resistant syndromes.

Pseudogout is caused by rhomboid-shaped calcium pyrophosphate crystals deposition (CPPD) into the joint space, which leads to symptoms that closely resemble gout. Typically occurring in one or two joints, such as the knee, ankles, wrists, or shoulders, pseudogout can last between one day and four weeks and is self-limiting in nature. A major predisposing factor is the presence of elevated levels of pyrophosphate in the synovial fluid. Because pyrophosphate excess can result from cellular injury, pseudogout is often precipitated by trauma, surgery, or severe illness. A deficiency in alkaline phosphatase, the enzyme responsible for breaking down pyrophosphate, is another potential cause of pyrophosphate excess. Other disorders associated with synovial CPPD include hyperparathyroidism, hypothyroidism, hemochromatosis, and Wilson disease. Unlike gout, pseudogout affects both men and women, with more than half at age 85 and older.

Infectious arthritides are a set of arthritic conditions caused by exposure to certain microorganisms. In some instances the microorganisms infiltrate the joint space and cause destruction, whereas in others an infection stimulates an inappropriate immune response leading to reactive arthritis. Typically caused by bacterial infections, infectious arthritis may also result from fungal and viral infections.

Septic arthritis usually affects a single large joint, such as the knee. Although a multitude of organisms may cause arthritis, Staphylococcus aureus is the most common pathogen. Neisseria gonorrhoeae, the bacteria that causes gonorrhea, is a common pathogen affecting sexually active young adults.

The most common way by which bacteria enter the joint space is through the circulatory system after a bloodstream infection. Microorganisms may also be introduced into the joint by penetrating trauma or surgery. Factors that increase the risk of septic arthritis include very young or old age (e.g., infants and the elderly), recent surgery or skin infection, preexisting arthritic condition, immunosuppression, chronic renal failure, and the presence of a prosthetic joint.

Postinfectious arthritis is seen after a variety of infections. Certain gastrointestinal infections, urinary tract infections, and upper respiratory tract infections can lead to arthritic symptoms after the infections themselves have resolved. Examples include Reiter syndrome and arthritis associated with rheumatic fever.

Go here to see the original:
arthritis | disease | Britannica.com

Read More...

Arthritis | ASPCA

September 3rd, 2015 1:44 pm

Canine arthritis, also known as osteoarthritis or degenerative joint disease, is characterized by pain and inflammation in a dogs joints. Arthritis is caused by the breaking down of smooth cartilage that covers and protects the bones that form a joint. Once the bones are exposed, painful wear and tear can occur.

Dogs who have canine arthritis may:

A veterinarian may conduct a physical exam, take radiographs and perform other diagnostic tests to help determine the cause of your dogs pain. He or she will also check your dogs medical history for previous injuries and consider possible inherited conditions.

Canine arthritis can occur as a result of:

Note: If a larger dog suffers any injuries or sprains during his growth period, this can cause him to develop arthritis later in life.

Although certain larger breed dogs such as mastiffs and Great Danes are susceptible to arthritis, the condition can develop in all breeds and mixed breeds as the result of joint infection, dislocation, trauma or family genetics. Elder dogs also often develop arthritis as a result of aging.

Keeping your dog fit with exercise and proper nutrition may, in some cases, help prevent arthritis, or possibly slow its progression once the condition has set in. In fact, if your dog is a larger breed, it's necessary to monitor the type and amount of food given when his bones are still growing. However, arthritic conditions cannot always be predicted or prevented, especially those that are inherited.

Once symptoms of arthritis set in, there is no cure. Its important for you to work with your veterinarian to create a program to minimize your dogs pain while keeping him healthy. Some general treatment options may include:

Note: Please do not give your dog human medication without first checking with your vet.

Generally, dogs with arthritis should engage in daily low-impact exercise such as walking or, if possible, swimming.

If your dog has arthritis, here are a few ways that you can make her more comfortable.

More here:
Arthritis | ASPCA

Read More...

Rheumatoid Arthritis: Medication, Treatment and Diet Facts

September 3rd, 2015 1:44 pm

Rheumatoid Arthritis Rheumatoid Arthritis Overview

Rheumatoid arthritis is a chronic joint disease that damages the joints of the body. It is also a systemic disease that potentially affects internal organs of the body and leads to disability. The joint damage is caused by inflammation of the joint lining tissue. Inflammation is normally a response by the body's immune system to "assaults" such as infections, wounds, and foreign objects. In rheumatoid arthritis, the inflammation is misdirected to attack the joints. Rheumatoid arthritis is often referred to as RA.

Rheumatoid arthritis can be confused with other forms of arthritis, such as osteoarthritis or arthritis associated with infections. Rheumatoid arthritis is an autoimmune disease. This means that the body's immune system mistakenly attacks the tissues it is supposed to protect.

Rheumatoid arthritis most often affects the smaller joints, such as those of the hands and/or feet, wrists, elbows, knees, and/or ankles, but any joint can be affected. The symptoms often lead to significant discomfort and disability.

Although rheumatoid arthritis most often affects the joints, it is a disease of the entire body. It can affect many organs and body systems besides the joints. Therefore, rheumatoid arthritis is referred to as a systemic disease.

Medically Reviewed by a Doctor on 5/11/2015

Read the original post:
Rheumatoid Arthritis: Medication, Treatment and Diet Facts

Read More...

Arthritis – Arthritis Causes – Symptoms, Treatments, and …

September 3rd, 2015 1:44 pm

Arthritis is a general term for more than 100 diseases that cause inflammation, pain, stiffness and swelling of joints. Common types of arthritis include:

Osteoarthritis - an ongoing, progressive disease that affects the joints as cartilage breaks down over time. Osteoarthritis is also called degenerative joint disease.

Rheumatoid arthritis - an autoimmune disease that affects the joints of the body with episodes of painful inflammation. Rheumatoid arthritis also affects other organs of the body and can result in the destruction of joints, disability, and, in severe cases, life-threatening complications.

Septic arthritis - arthritis caused by the infection of a joint by microorganisms, such as bacteria or fungi.

Complications of all forms of arthritis can be serious and include destruction of the joints, leading to disability. Rheumatoid arthritis and septic arthritis can also lead to serious or life-threatening complications that can affect almost any organ in the body.

Seek prompt medical care if you have symptoms of arthritis, such as inflammation, pain, stiffness, and swelling of joints. Early diagnosis and treatment can minimize discomfort and reduce the risk of serious complications.

2015 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

View Sources

Originally posted here:
Arthritis - Arthritis Causes - Symptoms, Treatments, and ...

Read More...

Arthritis & Joint Pain – Orthopedics Advice from About.com

September 3rd, 2015 1:44 pm

Image Medical Multimedia Group What is Arthritis?

Arthritis is a condition that causes inflammation of joint. While there are many types of arthritis, all types cause joint inflammation. Common complaints of people with arthritis include joint pain, swelling, and stiffness.

Arthritis come in many different types, and can affect any joint. Determining the best treatment for your arthritis will depend on identifying the type of arthritis and determining which joints are affected.

Common symptoms of arthritis include joint pain, swelling, and limited movement. The severity of symptoms of arthritis tends to correspond to the degree of inflammation of the joint.

Once you have determined the type of arthritis, you can review potential treatments for your condition. Most often, doctors will recommend trying simpler treatments for arthritis first to determine if your condition can be managed with minimal intervention.

Joint replacement surgery is generally considered a last-step treatment for the most severe cases of joint arthritis. Joint replacement surgery uses artificial joints to take the place of your worn out joint.

The best way to avoid problems associated with arthritis is to try to prevent progression of the condition. For people who have had arthritis in one joint, it is important to prevent the progression of arthritis in other joints.

View original post here:
Arthritis & Joint Pain - Orthopedics Advice from About.com

Read More...

Page 1,177«..1020..1,1761,1771,1781,179..1,1901,200..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick